State News

Displaying results 1-10 (of 72)
 |<  < 1 2 3 4 5 6 7 8  >  >| 

FDA Creates Pathway for Interchangeable Biologics

The FDA has released its highly anticipated but long delayed interchangeability guidelines, and the market seems primed for new developments.

READ MORE

States move to enforce FDA’s Biosimilar Interchangeability Guidelines from the Ground Up

The Food and Drug Administration’s guidelines for biosimilar interchangeability, released in January 2017, have come under renewed focus with concerns about patients being switched onto biosimilars by insurers without consultation with their physicians.

READ MORE

California Takes Aim at Pharmacy Benefit Managers With Assembly Bill 315

California’s Assembly Bill 315, which takes aim at Pharmacy Benefit Managers (PBMs), recently cleared the Assembly floor, and is now headed to the Senate for consideration.

READ MORE

State Rheumatology Organizations Join Alliance for Transparent & Affordable Prescriptions

The Florida Society of Rheumatology, New York State Rheumatology Society, and California Rheumatology Alliance today became the newest members of the Alliance for Transparent & Affordable Prescriptions (ATAP), a new coalition of provider and patient groups concerned about the role of pharmacy benefit managers (PBMs) in driving up drug costs.

READ MORE

The Atlantic Hosts Biosimilars Policy Roundtable.

The Atlantic recently concluded its policy roundtable on biosimilars June 7th, with the third and final installment titled: “The Next Drugs: An Atlantic Policy Update on Biosimilars.”

READ MORE

Maryland Enacts Biosimilars Bill

Maryland became the 35th state to approve of regulations and access for biosimilar medicines.

READ MORE

Minnesota Enacts HF712

Minnesota's Governor signed HF712 into law, a bill for biosimilars.

READ MORE

Step Therapy Legislative Update: Texas Governor Signs Step Therapy Bill into Law

The CSRO is pleased to announce that Texas Governor Greg Abbott has officially signed step therapy bill SB 680 into law.

READ MORE

ARA: CSRO Vice President Presents on PBMs and the Rebate System

The CSRO is pleased to report that CSRO Vice President Madeleine Feldman, MD, FACR, presented at the Arkansas Rheumatology Association, giving attendees an inside look at rising drug prices and the hidden rebate system controlled by pharmacy benefit managers (PBMs).

READ MORE

Biosimilars Bill headed to Nebraska Governor

Legislation that provides the substitution and regulation of biosimilars, LB481, was approved by Nebraska’s Unicameral Legislature on a vote of 47 – 0. The bill now goes to Governor Pete Ricketts for his expected signature.

READ MORE

Displaying results 1-10 (of 72)
 |<  < 1 2 3 4 5 6 7 8  >  >|